Securities Registration (section 12(g)) (8-a12g)
07 May 2015 - 6:46AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF
SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF
THE
SECURITIES EXCHANGE ACT OF l934
Ekso Bionics Holdings, Inc.
(Exact name of Registrant as specified
in its charter)
Nevada |
|
99-0367049 |
(State of incorporation or organization) |
|
(I.R.S. Employer Identification No.) |
|
|
1414 Harbour Way South, Suite 1201
Richmond, California |
|
94804 |
(Address of principal executive offices) |
|
(Zip Code) |
Securities to be registered pursuant to Section 12(b) of
the Act: None
Title of each class
to
be so registered |
|
Name of each exchange on which
each
class is to be registered |
N/A |
|
N/A |
If this form relates to the registration of a class of securities
pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), check the following
box. ¨
If this form relates to the registration of a class of securities
pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), check the following
box. x
Securities Act registration statement file number to which this
form relates:
Securities to be registered pursuant to Section 12(g) of
the Act:
Common stock, par value of $0.001
(Title of Class)
Item 1. |
Description of Registrant’s Securities to be Registered. |
The description of the common stock, par
value $0.001 per share, of Ekso Bionics Holdings, Inc. (“Registrant”) set forth under the caption “Description
of Securities” in Registrant’s Registration Statement on Form S-1 (as amended, the “Registration Statement”)
initially filed with the Securities and Exchange Commission (the “SEC”) on May 7, 2014 and declared effective on June
20, 2014 (File Number 333-195783) is incorporated herein by reference. Any prospectus subsequently filed pursuant to Rule 424(b)
under the Securities Act of 1933, as amended, that includes such description of the common stock shall be deemed to be incorporated
herein by reference.
The following Exhibits are incorporated
herein by reference pursuant to Rule 12b-32 of the Securities Exchange Act of 1934, as amended:
Exhibit |
|
|
Number |
|
Description |
|
|
|
3.1 |
Articles of
Incorporation of the Registrant (incorporated by reference from identically numbered exhibit filed with the
Registrant’s Registration Statement on Form S-1 filed with the SEC on May 8, 2012) |
|
|
3.2 |
Certificate of Amendment of Articles of Incorporation of the Registrant (incorporated by reference from identically numbered exhibit filed with the Registrant’s Current Report on Form 8-K filed with the SEC on January 23, 2014) |
|
|
3.3 |
Certificate of Merger
of Ekso Bionics, Inc., with Ekso Acquisition Corp., filed January 15, 2014 (incorporated by reference from identically numbered
exhibit filed with the Registrant’s Current Report on Form 8-K filed with the SEC on January 23,
2014) |
|
|
3.4 |
By-Laws of the Registrant (incorporated by reference from identically numbered exhibit filed with the Registrant’s Current Report on Form 8-K filed with the SEC on January 23, 2014) |
|
|
10.1 |
Form of Lock-Up
Agreement between the Registrant and the officers, directors and shareholders party thereto (incorporated by reference
from Exhibit 10.4 to the Registrant’s Current Report on Form 8-K filed with the SEC on January 23,
2014) |
|
|
10.2 |
Form of Subscription
Agreement between the Registrant and the investors party thereto (incorporated by reference from Exhibit 10.5 to the
Registrant’s Current Report on Form 8-K filed with the SEC on January 23, 2014) |
|
|
10.3 |
Form of Registration
Rights Agreement (incorporated by reference from Exhibit 10.10 of the Registrant’s Current Report on Form 8-K filed
with the SEC on January 23, 2014) |
|
|
10.4 |
Ekso Bionics Holdings,
Inc. 2014 Equity Incentive Plan (incorporated by reference from Exhibit 10.12 to the Registrant’s Current Report
on Form 8-K filed with the SEC on January 23, 2014) |
SIGNATURE
Pursuant to the requirements of Section 12
of the Securities Exchange Act of 1934, the Registrant has duly caused this registration statement to be signed on its behalf by
the undersigned, thereunto duly authorized.
|
EKSO BIONICS HOLDINGS, INC. |
|
|
|
|
|
|
|
By: |
/s/ Nathan Harding |
|
Name: |
Nathan Harding |
|
Title: |
Chief Executive Officer |
Dated: May 6, 2015
Ekso Bionics (NASDAQ:EKSO)
Historical Stock Chart
From Apr 2024 to May 2024
Ekso Bionics (NASDAQ:EKSO)
Historical Stock Chart
From May 2023 to May 2024